Gunjan Agrawal

Gunjan Agrawal

Auto-generated profile, based on publicly available information

Gunjan Agrawal

University of Rochester

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 July 2025 in Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
Verified
Journal Article
Closed access
GAGunjan Agrawal
Gunjan Agrawal
GAGhida Askar
Ghida Askar
TKTanvi Kaur
Tanvi Kaur
DKDiya Kamdar
Diya Kamdar
SKSanjana Santhosh Kumar
Sanjana Santhosh Kumar
JKJunad Khan
Junad Khan

15 September 2026 in Headache Medicine
Verified
Journal Article
Open access
PDF file
GAGunjan Agrawal
Gunjan Agrawal
GKGurleen Kaur
Gurleen Kaur
SKSanjana Santhosh Kumar
Sanjana Santhosh Kumar
MAMaryam Rjab Altuhafy
Maryam Rjab Altuhafy
junaid khanjunaid khan
junaid khan
IntroductionMigraine is a disabling neurological disorder often linked with neuroinflammation, with many patients experiencing only partial relief from existing pharmacological treatments. Omega-3 fatty acids and nano-curcumin, known for their anti-inflammatory and neuroprotective properties, are promising adjunctive or alternative strategies for migraine management. ObjectiveThis review aims to evaluate the combined efficacy of omega-3 fatty acids and nano-curcumin in reducing the frequency, duration, and intensity of migraine attacks, and to elucidate their potential mechanisms of action by modulating inflammatory and neuroprotective pathways. MethodsA total of 1,632 articles were initially retrieved through electronic database searches. Once duplicate records were removed, an additional search of reference lists from pertinent publications was performed. After screening the titles and abstracts, five studies were shortlisted for full-text assessment. ResultsThe combined use of omega-3 fatty acids and nano-curcumin significantly reduces the number, frequency, and severity of migraine attacks. This synergistic effect is attributed to their ability to modulate inflammatory and neuroinflammatory pathways, offering a promising adjunctive therapy. Current evidence suggests that the combination of omega-3 fatty acids and nano-curcumin results in a significant reduction in migraine frequency and severity compared to either supplement alone. The synergistic interaction between these agents enhances anti-inflammatory responses and neuronal protection, contributing to improved clinical outcomes and complementing conventional migraine therapies. ConclusionsThe concurrent use of omega-3 fatty acids and nano-curcumin demonstrates promising therapeutic potential in migraine management. Nonetheless, further large-scale, long-term clinical trials are warranted to validate these findings and to establish optimal dosage regimens and treatment durations.